2023-2024 Regular SessionIllinois Legislature

HB5355: NONOPIOID ALTERNATIVES ACT

Legislative Summary

Creates the Nonopioid Alternatives for Pain Act. Requires the Department of Public Health to develop and publish an educational pamphlet regarding the use of nonopioid alternatives for pain treatment. Provides that a health care practitioner shall exercise professional judgment in selecting appropriate treatment modalities for pain in accordance with specified Centers for Disease Control and Prevention guidelines, including the use of nonopioid alternatives whenever nonopioid alternatives exist. Requires a health care practitioner who prescribes an opioid drug to provide certain information to the patient, discuss certain topics, and document the reasons for the prescription. Requires the Department to develop a nonopioid directive form for patients. Sets forth provisions concerning exceptions, execution of a nonopioid directive, opioid administration to a patient with a nonopioid directive, and limitations of liability. Amends the Illinois Insurance Code. Provides that when a licensed health care practitioner prescribes a nonopioid medication for the treatment of acute pain, it shall be unlawful for a health insurance issuer to deny coverage of the nonopioid prescription drug in favor of an opioid prescription drug or to require the patient to try an opioid prescription drug before providing coverage. Provides that in establishing and maintaining its drug formulary, a health insurance issuer shall ensure that no nonopioid drug approved by the Food and Drug Administration for the treatment or management of pain shall be disadvantaged or discouraged, with respect to coverage or cost sharing, relative to any opioid or narcotic drug for the treatment or management of pain. Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that whenever a licensed health care practitioner prescribes a nonopioid medication for the treatment of acute pain, neither the Department of Healthcare and Family Services nor a managed care organization shall deny coverage of the nonopioid prescription drug in favor of an opioid prescription drug or require a patient to try an opioid prescription drug prior to providing coverage of the nonopioid prescription drug. Makes other changes.

Demographic Impact

Overall analysis of equity impact

80% Positive
High ConfidenceView detailed demographic breakdown ↓

Unlock Full Demographic Insights

Go beyond the overall score.

Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.

Enable full analysis features for your organization.

Contact Sales to Learn More

Or email us directly at sales@legiequity.us.

Bill History

2/9/2024
Filed with the Clerk by Rep. Lindsey LaPointe
House of Representatives
2/9/2024
First Reading
House of Representatives
2/9/2024
Referred to Rules Committee
House of Representatives
3/5/2024
Assigned to Health Care Availability & Accessibility Committee
House of Representatives
3/7/2024
Chief Sponsor Changed to Rep. Janet Yang Rohr
House of Representatives
3/7/2024
Added Chief Co-Sponsor Rep. Lindsey LaPointe
House of Representatives
4/2/2024
Do Pass / Short Debate Health Care Availability & Accessibility Committee; 010-000-000
House of Representatives
4/3/2024
Placed on Calendar 2nd Reading - Short Debate
House of Representatives
4/12/2024
Added Co-Sponsor Rep. Laura Faver Dias
House of Representatives
4/16/2024
House Floor Amendment No. 1 Filed with Clerk by Rep. Janet Yang Rohr
House of Representatives
4/16/2024
House Floor Amendment No. 1 Referred to Rules Committee
House of Representatives
4/17/2024
House Floor Amendment No. 1 Rules Refers to Health Care Availability & Accessibility Committee
House of Representatives
4/17/2024
Added Chief Co-Sponsor Rep. William E Hauter
House of Representatives
4/17/2024
Second Reading - Short Debate
House of Representatives
4/17/2024
Held on Calendar Order of Second Reading - Short Debate
House of Representatives
4/17/2024
House Floor Amendment No. 1 Recommends Be Adopted Health Care Availability & Accessibility Committee; 011-000-000
House of Representatives
4/18/2024
Added Chief Co-Sponsor Rep. Kevin Schmidt
House of Representatives
4/18/2024
House Floor Amendment No. 1 Adopted
House of Representatives
4/18/2024
Placed on Calendar Order of 3rd Reading - Short Debate
House of Representatives
4/18/2024
Third Reading - Short Debate - Passed 108-000-000
House of Representatives
4/19/2024
Arrive in Senate
Senate
4/19/2024
Placed on Calendar Order of First Reading
Senate
4/19/2024
Chief Senate Sponsor Sen. Karina Villa
Senate
4/19/2024
First Reading
Senate
4/19/2024
Referred to Assignments
Senate
5/15/2024
Added Co-Sponsor Rep. La Shawn K. Ford
House of Representatives
12/3/2024
Added as Alternate Co-Sponsor Sen. Mike Porfirio
Senate
12/5/2024
Added as Alternate Co-Sponsor Sen. Cristina Castro
Senate
12/5/2024
Added as Alternate Co-Sponsor Sen. Natalie Toro
Senate
12/5/2024
Added as Alternate Co-Sponsor Sen. Mary Edly-Allen
Senate
12/10/2024
Added as Alternate Co-Sponsor Sen. Adriane Johnson
Senate
12/10/2024
Added as Alternate Co-Sponsor Sen. Julie A. Morrison
Senate
12/11/2024
Added as Alternate Co-Sponsor Sen. Laura Fine
Senate
12/13/2024
Added as Alternate Co-Sponsor Sen. Michael W. Halpin
Senate
12/16/2024
Added as Alternate Co-Sponsor Sen. Christopher Belt
Senate
12/16/2024
Added as Alternate Chief Co-Sponsor Sen. Mattie Hunter
Senate
12/16/2024
Added as Alternate Co-Sponsor Sen. Robert Peters
Senate
12/17/2024
Added as Alternate Chief Co-Sponsor Sen. Kimberly A. Lightford
Senate
12/19/2024
Added as Alternate Co-Sponsor Sen. Sara Feigenholtz
Senate
12/20/2024
Added as Alternate Co-Sponsor Sen. Javier L. Cervantes
Senate
12/20/2024
Added as Alternate Co-Sponsor Sen. Doris Turner
Senate

Amendments

House Amendment 001

House Amendment 001

4/16/2024Not Adopted

Roll Call Votes

Third Reading in House
4/18/2024
108
Yea
0
Nay
0
Not Voting
2
Absent
Result: PASSED